Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety

MLA

Kelly L. Hayward, et al. “Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety.” Pharmaceuticals, vol. 14, no. 12, Nov. 2021, p. 1207. EBSCOhost, https://doi.org/10.3390/ph14121207.

APA

Kelly L. Hayward, Patricia C. Valery, Preya J. Patel, Catherine Li, Leigh U. Horsfall, Penny L. Wright, Caroline J. Tallis, Katherine A. Stuart, Michael David, Katharine M. Irvine, Neil Cottrell, Jennifer H. Martin, & Elizabeth E. Powell. (2021). Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety. Pharmaceuticals, 14(12), 1207. https://doi.org/10.3390/ph14121207

Chicago

Kelly L. Hayward, Patricia C. Valery, Preya J. Patel, Catherine Li, Leigh U. Horsfall, Penny L. Wright, Caroline J. Tallis, et al. 2021. “Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety.” Pharmaceuticals 14 (12): 1207. doi:10.3390/ph14121207.